Cefuroxime 250Mg + Potassium Clavulanate 125mg

Get a Price/Quote

MOQ : 100 Boxes

Cefuroxime 250Mg + Potassium Clavulanate 125mg Specification

Salt Composition
Cefuroxime 250Mg + Potassium Clavulanate 125mg

Pacakaging (Quantity Per Box)
10x6

Dosage Form
Tablets

Ingredients
The combination of Cefuroxime 250mg and Potassium Clavulanate 125mg is a potent, broad-spectrum antibiotic used to treat a wide range of bacterial infections, especially those that may be resistant to other antibiotics.

Physical Form
Tablets

Dosage
Tablets

Quantity
100 Boxes

Cefuroxime 250Mg + Potassium Clavulanate 125mg Trade Information

Minimum Order Quantity
100 Boxes

Delivery Time
7 Days

About Cefuroxime 250Mg + Potassium Clavulanate 125mg

The combination of Cefuroxime 250mg and Potassium Clavulanate 125mg is a potent, broad-spectrum antibiotic used to treat a wide range of bacterial infections, especially those that may be resistant to other antibiotics.

How It Works

This medication combines two active ingredients:

Cefuroxime is a second-generation cephalosporin antibiotic that works by preventing the formation of the bacterial cell wall, which is essential for the bacteria's survival, thus killing them.

Potassium Clavulanate is a beta-lactamase inhibitor. Some bacteria produce an enzyme called beta-lactamase which can inactivate cefuroxime. The clavulanate blocks this enzyme, thereby enhancing the activity and effectiveness of cefuroxime against these resistant bacteri

Broad-Spectrum Infection Management

The dual-action formula takes on a wide array of bacterial infections by combining the bactericidal effects of Cefuroxime with the protective qualities of Potassium Clavulanate. This combination is especially effective for treating infections that may not respond fully to other antibiotics.

Convenient and Practical Packaging

Each package consists of 10 strips, with 6 tablets per strip, in a total of 100 boxes. This configuration is designed for easy distribution to clinics and hospitals, ensuring streamlined inventory control and practical usage for patients.

Enhanced Resistance Protection

Potassium Clavulanate prevents bacterial resistance by inhibiting beta-lactamase enzymes, enabling Cefuroxime to remain effective even against resistant strains. This makes the tablets highly beneficial in both standard cases and those where resistance is a concern.

FAQ's of Cefuroxime 250Mg + Potassium Clavulanate 125mg:

Q: How should Cefuroxime 250mg + Potassium Clavulanate 125mg tablets be taken?

A: These tablets should be taken orally with or without food, as directed by a healthcare professional. The dosing frequency and duration depend on the specific infection being treated. Always complete the course prescribed, even if symptoms improve earlier.

Q: What bacterial infections can this combination treat?

A: This combination is effective against various infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and certain ENT infections, especially those caused by bacteria resistant to other antibiotics.

Q: When is the use of this product particularly recommended?

A: It is especially recommended when treating infections that may involve bacteria resistant to standard antibiotics, or in cases where previous antibiotic therapies have been ineffective.

Q: Where should these tablets be stored for optimal efficacy?

A: Store the tablets in a cool, dry place, away from sunlight and moisture, and out of the reach of children. Follow all storage instructions on the packaging to maintain potency.

Q: What is the process for ordering and receiving these tablets?

A: Healthcare providers, suppliers, and traders can place orders for boxes (each containing 60 tablets), and the tablets are shipped according to standard pharmaceutical supply protocols. Contact the manufacturer or authorized suppliers to ensure proper procurement.

Q: What are the benefits of this antibiotic combination compared to individual components?

A: The combination provides enhanced antibacterial coverage, reducing the risk of resistance and improving treatment outcomes compared to Cefuroxime alone, as Potassium Clavulanate neutralizes beta-lactamase enzymes produced by resistant bacteria.

Tell us about your requirement